CIIT vs JNJ · rev $9.3M vs P/E 17, rev $49.37B
Tianci International, Inc. Common Stock (CIIT) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Tianci International, Inc. Common Stock (CIIT) is a integrated freight & logistics company listed on NASDAQ.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CIIT revenue for 2025-07-31 was $9.3M. Net income was -$2.7M. CIIT currently screens at market cap $2.1M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CIIT currently screens at market cap $2.1M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CIIT and JNJ stock pages for the full models.
Not investment advice.